Physician profile
Terry Yu
NPI 1346737467
$2,860.84
in general payments reported to CMS, 2019-2025
17 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $158 · 2021: $394 · 2022: $609 · 2023: $450 · 2024: $594 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $1,205.84 | 2019-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $303.71 | 2019 | |
| Bausch & Lomb Americas INC. | $159.61 | 2022-2024 | Vyzulta, Xiidra |
| Tarsus Pharmaceuticals, INC. | $152.02 | 2024-2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $150.86 | 2019-2021 | |
| Abbvie INC. | $142.60 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $124.99 | 2020 | |
| Alcon Vision LLC | $116.33 | 2024 | Eysuvis |
| Dompe US, INC. | $115.12 | 2022 | |
| Oyster Point Pharma, INC. | $112.95 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Glaukos Corporation | $111.14 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $63.17 | 2023-2024 | Tecnis Iol, Tecnis Simplicity, Lipiflow System Activator (Disposable) |
| Mallinckrodt Hospital Products INC. | $30.27 | 2025 | Acthar |
| Rxsight INC | $23.25 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Ani Pharmaceuticals, INC. | $22.32 | 2025 | Yutiq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $18.95 | 2023 | Acuvue |
| Alimera Sciences, INC. | $7.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.